Novo Nordisk recently got approval from Health Canada to market semaglutide under the additional names of names Plosbrio and Poviztra, which the company said it may use to compete with the cheaper generics
Always inform your doctor about any new or unusual symptoms you experience, especially chest pain
This article explores the guidelines for blood donation while on GLP-1 medications, the physiological factors that matter most, and how to prepare for a successful donation
21 (UPI) -- Zepbound, the new GLP-1 weight-loss drug from Eli Lilly & Co., has been approved by the Food and Drug Administration for treating moderate to severe obstructive sleep apnea
It reads pathway-level variants such as FTO that describe your baseline metabolic biology, offering context for a conversation with your provider rather than a treatment forecast
Potential Health Benefits Weight loss meds can lower blood pressure, blood sugar, and triglycerides